SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia
{{output}}
Background: Obesity confers an increased risk and accelerates the progression of multiple tumor types in rodents and humans, including both breast and colon cancer. Because sustained weight loss is rarely achieved, therapeutic ap... ...
